Tech Company Financing Transactions

Excelimmune Funding Round

Excelimmune closed a $4.5 million Series B funding round on 7/7/2010. Investors included private investors.

Transaction Overview

Company Name
Announced On
7/7/2010
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1776 Massachusetts Ave.
Lexington, MA 02420
USA
Email Address
Overview
Excelimmune is a biopharmaceutical company developing fully human recombinant polyclonal antibodies for therapeutics.
Profile
Excelimmune LinkedIn Company Profile
Social Media
Excelimmune Company Twitter Account
Company News
Excelimmune News
Facebook
Excelimmune on Facebook
YouTube
Excelimmune on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elizabeth Reczek
  Elizabeth Reczek LinkedIn Profile  Elizabeth Reczek Twitter Account  Elizabeth Reczek News  Elizabeth Reczek on Facebook
Chief Financial Officer
Jason Walsh
  Jason Walsh LinkedIn Profile  Jason Walsh Twitter Account  Jason Walsh News  Jason Walsh on Facebook
VP - Product Management
Thomas Dahl
  Thomas Dahl LinkedIn Profile  Thomas Dahl Twitter Account  Thomas Dahl News  Thomas Dahl on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/7/2010: Echogen Power Systems venture capital transaction
Next: 7/7/2010: ThredUP venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary